Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lilly's ads can continue after Novo challenge, judge rules

Novo Nordisk has suffered another setback in its uphill battle against Eli Lilly in the booming obesity drug market after a US judge rejected its attempt to block television ads that Novo alleges are misleading. ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 27 October →